Fractal invariance of relative neurodegenerative tissue vulnerability: An onto-phylogenetic field validated on the TDP-43 spectrum

In the study of the brain's decline, a stubborn mystery has long puzzled scientists: why do some specific groups of nerve cells die first in diseases like amyotrophic lateral sclerosis (ALS) or frontotemporal dementia, while their immediate neighbors remain untouched? For decades, researchers have tried to map this selective vulnerability, often viewing it as a flaw in the cells themselves or a random accident of aging. Some theories suggested that the oldest parts of the brain, those built early in our evolutionary history, are the first to crumble. Others argued that the newest, most complex parts of the human brain are too expensive to maintain and fail first. These debates have remained stuck because traditional methods of looking at brain tissue are static; they take a single snapshot of a damaged brain and try to guess the order in which things broke, without understanding the underlying forces that guided the damage in the first place.

A new study by Felix Geser proposes a radical shift in how we view this problem. Instead of looking for a broken part, Geser suggests that the brain's vulnerability is built into its very architecture, like a landscape with natural valleys and peaks. He developed a mathematical map that treats the human nervous system not as a collection of isolated spots, but as a continuous, three-dimensional terrain shaped by two deep biological histories. One history is the evolutionary timeline, measuring how much a brain region has grown and changed over millions of years. The other is the developmental timeline, measuring how long it took for that specific region to finish building itself during human growth. By combining these two timelines, the study creates a topographic map of the brain where some areas sit in deep, low-energy valleys and others rise on high, well-buffered plateaus.

The core finding of this research is that neurodegenerative diseases do not attack randomly. Instead, they follow the path of least resistance across this pre-existing landscape. The study demonstrates that the disease acts like water flowing downhill, naturally seeking out the lowest, most fragile points in the brain's structural terrain first. In the case of ALS, the disease begins in the spinal cord, which sits in a deep, low-energy valley with very little structural buffer to protect it. It then flows upward, moving through the brainstem and into the motor cortex, climbing the steep, energy-rich slopes of the brain's newer structures. The research shows that this path is determined by the geometry of the healthy brain itself, long before any disease protein ever appears. The specific type of protein causing the illness matters less than the shape of the terrain it is traveling through.

To build this map, the researchers analyzed twenty-five distinct anatomical nodes across the human central nervous system, ranging from the spinal cord to the prefrontal cortex. They plotted each node based on its evolutionary expansion and its developmental time budget. The results revealed a stark divide between the ancient, conservative parts of the brain and the modern, highly expanded neocortex. The ancient parts, such as the spinal cord and lower brainstem, showed almost no correlation between their size and their development time; they are small, built quickly, and sit in a state of low energy. In contrast, the modern neocortex follows a strict, predictable rule where massive growth is paired with a long, extended period of development. This creates a high-energy "canopy" at the top of the brain, which acts as a powerful shield against collapse.

When the researchers applied this model to the progression of TDP-43 proteinopathies—a group of diseases including ALS, frontotemporal lobar degeneration, and a condition called LATE-NC—the map explained the disease's behavior with surprising precision. In classic ALS, the disease starts in the spinal cord and moves up to the brainstem and then the motor cortex. The study found that this path is not a random choice but a thermodynamic necessity. The spinal cord has the lowest energy reserves, making it the easiest point for the disease to ignite. As the disease moves up, it encounters increasingly steep, high-energy barriers. It must expend more effort to cross from the brainstem to the motor cortex, and even more to reach the prefrontal cortex, which sits at the highest point of the brain's energy landscape. This explains why the disease takes so long to reach the thinking and planning centers of the brain; it is literally climbing a mountain of structural resilience.

The model also resolved a long-standing confusion about frontotemporal lobar degeneration. In the early stages of this disease, the pattern of damage appears scattered and unpredictable, with different patients showing symptoms in different areas. The study suggests this is not because the disease is chaotic, but because it is hitting multiple low-energy points in the brain's middle layers simultaneously. However, once the disease exhausts these local buffers, it converges on a single, inevitable path. The study found that in the late stages of frontotemporal lobar degeneration, the disease follows the exact same route as classic ALS, moving down into the spinal cord. This convergence proves that the underlying geometry of the brain dictates the final destination of the disease, regardless of where it started.

Similarly, the study explained the behavior of LATE-NC, a condition that primarily affects memory and the limbic system. The map showed that the hippocampus, a key memory structure, sits in a unique position. It is surrounded by a tight cluster of structures that act as a continuous, low-resistance basin. The disease flows easily into this basin, filling it up slowly. The hippocampus itself acts as a massive energy sink, absorbing the damage and delaying the collapse of the rest of the brain. The study calculated that the hippocampus can hold off the disease for a long time because of its high structural investment, but once this buffer is finally exhausted, the disease must make a massive leap to reach the prefrontal cortex. This leap is so difficult, requiring a jump across a vast evolutionary and developmental gap, that the disease often never makes it, leaving the patient with memory loss but sparing their higher cognitive functions.

The researchers emphasize that this vulnerability is a relational property, meaning it only exists in the context of the brain's total structure. A cell is not vulnerable because it is old or new in isolation; it is vulnerable because of its position relative to the rest of the system. The study rejects the idea that we can understand these diseases by looking at a single cell or a single protein in a test tube. Instead, it argues that the brain is a unified field where the shape of the terrain determines the flow of the disease. The pathogenetic forces, such as genetic mutations or environmental stress, act as a trigger, but they do not choose the path. The path is already there, carved into the brain's developmental and evolutionary history.

This perspective changes how we might think about treating these conditions. If the disease is simply following the path of least resistance through a pre-existing landscape, then protecting the brain might not require stopping the disease protein directly. Instead, it might be possible to strengthen the terrain itself, raising the energy barriers that the disease must cross. The study suggests that the brain's natural defenses are built into its geometry, and understanding this geometry could reveal new ways to protect the most vulnerable pathways. By mapping the exact points where the structural tension is lowest, researchers can identify the precise break points where the system is most likely to fail.

The study concludes that the human brain is not a flat, uniform space where disease spreads randomly. It is a complex, curved landscape with deep valleys of vulnerability and high peaks of resilience. The progression of neurodegenerative diseases is a predictable journey across this terrain, governed by the same thermodynamic laws that govern the flow of water or the movement of heat. The specific disease, whether it is ALS or frontotemporal dementia, is merely the vehicle traveling this road. The road itself, the path of least resistance, is determined by the unique way the human brain grew and evolved. This framework unites different diseases under a single geometric rule, showing that the brain's architecture holds the key to understanding why it falls apart the way it does.